William K. Evans - Concepedia

Author

William K. Evans

University of Toronto ORCID

Also Known As

A T Skarin, C Roper, D M Logan , M Wishart, M. Trudeau, W EVANS, W Evans, W K Evans, W K. Evans, W. Evans

355

Publications

14.5K

Citations

H-Index

174

Concepts

All Affiliations

University of Toronto McMaster University University of Ottawa Ottawa Regional Cancer Foundation Cancer Care Ontario

About

William K. Evans is an author at University of Toronto specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	88	6.1K
2	Health Sciences	23	34	2.4K
3	Public Health	16	22	1.2K
4	Nursing	2	2	45
5	Biochemistry	1	1	33

William K. Evans

157

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Nevin Murray, P. Coy, Joseph L. Pater, Journal of Clinical Oncology	1993	725
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. E Rapp, Joseph L. Pater, Andrew R. Willan, Journal of Clinical Oncology OncologyCombination ChemotherapyCancer ManagementMetronomic TherapyClinical Trials	1988	699
Structured Exercise Improves Physical Functioning in Women With Stages I and II Breast Cancer: Results of a Randomized Controlled Trial Roanne Segal, William K. Evans, Darren Johnson, Journal of Clinical Oncology	2001	574
Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction. Eva Grunfeld, Timothy J. Whelan, Louise Zitzelsberger, PubMed	2000	455
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. Pierre Ruffiè, R. Feld, Salomon Minkin, Journal of Clinical Oncology Retrospective StudyAppropriate Stratification VariablesTumoral PathologyWeight LossMedicine	1989	371
Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline Katherine M.W. Pisters, William K. Evans, Christopher G. Azzoli, Journal of Clinical Oncology	2007	361
VP-16 and cisplatin as first-line therapy for small-cell lung cancer. William K. Evans, Frances A. Shepherd, Ronald Feld, Journal of Clinical Oncology Neuro-oncologyFirst-line TherapyLd PatientsMedicineCancer Management	1985	311
Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer William K. Evans Annals of Internal Medicine	1987	226
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study Martin C. Tammemägi, Heidi Schmidt, Simon Martel, The Lancet Oncology Tobacco ControlPreventive MedicineCancer EpidemiologyCancer DetectionCancer Screening	2017	207
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer. William K. Evans, David Osoba, Ronald Feld, Journal of Clinical Oncology Ld PatientsMedicinePathologySmall-cell Lung CancerEffective Treatment	1985	190

Page 1